AU2001276833A1 - Multiple stimulus reversible hydrogels - Google Patents

Multiple stimulus reversible hydrogels

Info

Publication number
AU2001276833A1
AU2001276833A1 AU2001276833A AU7683301A AU2001276833A1 AU 2001276833 A1 AU2001276833 A1 AU 2001276833A1 AU 2001276833 A AU2001276833 A AU 2001276833A AU 7683301 A AU7683301 A AU 7683301A AU 2001276833 A1 AU2001276833 A1 AU 2001276833A1
Authority
AU
Australia
Prior art keywords
multiple stimulus
reversible hydrogels
hydrogels
reversible
stimulus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001276833A
Inventor
Anna Gutowska
Karol J. Krzyminski
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Battelle Memorial Institute Inc
Original Assignee
Battelle Memorial Institute Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Battelle Memorial Institute Inc filed Critical Battelle Memorial Institute Inc
Publication of AU2001276833A1 publication Critical patent/AU2001276833A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials For Medical Uses (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
AU2001276833A 2000-06-23 2001-06-21 Multiple stimulus reversible hydrogels Abandoned AU2001276833A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09/603,730 US6660247B1 (en) 2000-06-23 2000-06-23 Multiple stimulus reversible hydrogels
US09/603,730 2000-06-23
PCT/US2001/020183 WO2002000193A2 (en) 2000-06-23 2001-06-21 Multiple stimulus reversible hydrogels

Publications (1)

Publication Number Publication Date
AU2001276833A1 true AU2001276833A1 (en) 2002-01-08

Family

ID=24416673

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001276833A Abandoned AU2001276833A1 (en) 2000-06-23 2001-06-21 Multiple stimulus reversible hydrogels

Country Status (6)

Country Link
US (2) US6660247B1 (en)
EP (1) EP1292280A2 (en)
JP (1) JP2004512389A (en)
AU (1) AU2001276833A1 (en)
CA (1) CA2412017A1 (en)
WO (1) WO2002000193A2 (en)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6660247B1 (en) * 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels
US20040185101A1 (en) * 2001-03-27 2004-09-23 Macromed, Incorporated. Biodegradable triblock copolymers as solubilizing agents for drugs and method of use thereof
US7649023B2 (en) * 2002-06-11 2010-01-19 Novartis Ag Biodegradable block copolymeric compositions for drug delivery
JP4909071B2 (en) * 2003-03-24 2012-04-04 プルーローメッド， インコーポレイテッド Temporary embolization using reverse thermosensitive polymers
NZ543288A (en) * 2003-04-30 2009-06-26 Univ Drexel Thermogelling polymer blends for biomaterial applications
AU2003267747A1 (en) * 2003-10-14 2005-05-05 Ramesh Varada Bapat Sterile gelling agents
WO2005046438A2 (en) * 2003-11-06 2005-05-26 Pluromed, Inc. Internal clamp for surgical procedures
US20070001156A1 (en) * 2004-08-04 2007-01-04 Toreki William Iii Degradable or reversible fire-blocking gel
US7201918B2 (en) * 2004-11-16 2007-04-10 Microvention, Inc. Compositions, systems and methods for treatment of defects in blood vessels
EP2034906A4 (en) * 2006-06-21 2010-07-28 Univ Leland Stanford Junior Compositions and methods for joining non-conjoined lumens
US8197499B2 (en) * 2006-06-21 2012-06-12 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8608760B2 (en) * 2006-06-21 2013-12-17 The Board Of Trustees Of The Leland Stanford Junior University Compositions and methods for joining non-conjoined lumens
US8030592B2 (en) * 2006-11-22 2011-10-04 Reintjes Marine Surface Technologies, Llc Apparatus and method for applying antifoulants to marine vessels
WO2008137872A1 (en) * 2007-05-04 2008-11-13 Personics Holdings Inc. Earguard sealing system i: multi-chamber systems
US20100015349A1 (en) * 2007-07-16 2010-01-21 Larry Weidman Marine antifoulant coating
US7910648B2 (en) * 2007-07-16 2011-03-22 Reintjes Marine Surface Technologies, Llc Marine antifoulant coating
US8480651B2 (en) * 2007-08-02 2013-07-09 Covidien Lp Cannula system
US9987221B2 (en) * 2007-08-23 2018-06-05 Boston Scientific Scimed, Inc. Injectable hydrogel compositions
US8718313B2 (en) * 2007-11-09 2014-05-06 Personics Holdings, LLC. Electroactive polymer systems
US8180447B2 (en) 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method for reversible chemical modulation of neural activity
US8170660B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for thermal modulation of neural activity
US8195287B2 (en) * 2007-12-05 2012-06-05 The Invention Science Fund I, Llc Method for electrical modulation of neural conduction
US8989858B2 (en) 2007-12-05 2015-03-24 The Invention Science Fund I, Llc Implant system for chemical modulation of neural activity
US8165669B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc System for magnetic modulation of neural conduction
US8170658B2 (en) 2007-12-05 2012-05-01 The Invention Science Fund I, Llc System for electrical modulation of neural conduction
US8180446B2 (en) * 2007-12-05 2012-05-15 The Invention Science Fund I, Llc Method and system for cyclical neural modulation based on activity state
US8165668B2 (en) * 2007-12-05 2012-04-24 The Invention Science Fund I, Llc Method for magnetic modulation of neural conduction
US20090149797A1 (en) * 2007-12-05 2009-06-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware System for reversible chemical modulation of neural activity
US8142870B2 (en) * 2007-12-13 2012-03-27 Personics Holdings Inc. Energy responsive conformal device
US8172861B2 (en) * 2007-12-20 2012-05-08 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
US8148501B2 (en) * 2008-02-22 2012-04-03 Battelle Memorial Institute Absorbent protein meal base hydrogels
US20100061976A1 (en) * 2008-07-24 2010-03-11 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing osteoporosis by reducing follicle stimulating hormone to cyclic physiological levels in a mammalian subject
US20100022487A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20100022497A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method for treating or preventing a cardiovascular disease or condition utilizing estrogen receptor modulators based on APOE allelic profile of a mammalian subject
US20100022494A1 (en) * 2008-07-24 2010-01-28 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Method, device, and kit for maintaining physiological levels of steroid hormone in a subject
US20110295089A1 (en) 2008-12-04 2011-12-01 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Systems, devices, and methods including implantable devices with anti-microbial properties
US8563037B2 (en) * 2009-02-06 2013-10-22 Tautona Group, L.P. Compositions and methods for joining non-conjoined lumens
US8167871B2 (en) 2009-02-25 2012-05-01 The Invention Science Fund I, Llc Device for actively removing a target cell from blood or lymph of a vertebrate subject
US8317737B2 (en) * 2009-02-25 2012-11-27 The Invention Science Fund I, Llc Device for actively removing a target component from blood or lymph of a vertebrate subject
RU2013142684A (en) 2011-02-22 2015-03-27 Реджентс Оф Юниверсити Оф Миннесота (Сша) SILICON DIOXIDE Encapsulated Biomaterials
US9422387B2 (en) 2012-03-30 2016-08-23 Kimberly-Clark Worldwide, Inc. Dual responsive block copolymer compositions
WO2014120591A1 (en) * 2013-01-29 2014-08-07 TauTona Group Research and Development Company, L.L.C. Thermoreversible sol-gel compositions for joining lumens
US9534236B2 (en) 2013-03-08 2017-01-03 Regents Of The University Of Minnesota Membranes for wastewater-generated energy and gas
US10392611B2 (en) 2013-05-30 2019-08-27 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
US10364451B2 (en) 2013-05-30 2019-07-30 Duke University Polymer conjugates having reduced antigenicity and methods of using the same
JP6226126B2 (en) * 2013-10-09 2017-11-08 国立大学法人滋賀医科大学 Vascular embolic agent
US9040629B1 (en) * 2013-11-07 2015-05-26 Xerox Corporation Thermally switchable composition
US10035719B2 (en) 2014-10-15 2018-07-31 Regents Of The University Of Minnesota System and membrane for wastewater-generated energy and gas
US10385115B2 (en) 2015-03-26 2019-08-20 Duke University Fibronectin type III domain-based fusion proteins
JP6882782B2 (en) 2015-08-04 2021-06-02 デューク ユニバーシティ Genetically encoded, essentially chaotic delivery stealth polymers and how to use them
CA3004745A1 (en) 2015-11-12 2017-05-18 University Of Virginia Patent Foundation Compositions and methods for vas-occlusive contraception and reversal thereof
US11752213B2 (en) 2015-12-21 2023-09-12 Duke University Surfaces having reduced non-specific binding and antigenicity
US11467156B2 (en) 2016-06-01 2022-10-11 Duke University Nonfouling biosensors
RU2019110848A (en) 2016-09-14 2020-10-15 Дьюк Юниверсити NANOPARTICLES BASED ON TRIBLOC POLYPEPTIDES FOR DELIVERY OF HYDROPHILIC MEDICINES
WO2018057847A1 (en) 2016-09-23 2018-03-29 Duke University Unstructured non-repetitive polypeptides having lcst behavior
CA3053451A1 (en) 2017-01-05 2018-07-12 Contraline, Inc. Methods for implanting and reversing stimuli-responsive implants
WO2018132732A1 (en) 2017-01-12 2018-07-19 Duke University Genetically encoded lipid-polypeptide hybrid biomaterials that exhibit temperature triggered hierarchical self-assembly
WO2018213320A1 (en) 2017-05-15 2018-11-22 Duke University Recombinant production of hybrid lipid-biopolymer materials that self-assemble and encapsulate agents
WO2019006374A1 (en) 2017-06-30 2019-01-03 Duke University Order and disorder as a design principle for stimuli-responsive biopolymer networks
EP3829622A4 (en) 2018-08-02 2022-05-11 Duke University Dual agonist fusion proteins
EP3880273A4 (en) 2018-11-13 2022-08-24 Contraline, Inc. Systems and methods for delivering biomaterials
US11512314B2 (en) 2019-07-12 2022-11-29 Duke University Amphiphilic polynucleotides
CN114618333B (en) * 2020-12-21 2023-06-20 南京工业大学 Efficient and controllable method for preparing dual-response block copolymer uniform pore membrane and application
WO2023287727A1 (en) 2021-07-12 2023-01-19 Boston Scientific Scimed, Inc. Radiopaque compositions

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732930A (en) 1985-05-20 1988-03-22 Massachusetts Institute Of Technology Reversible, discontinuous volume changes of ionized isopropylacrylamide cells
WO1989007117A1 (en) 1988-02-01 1989-08-10 Tyndale Plains-Hunter, Ltd. Thermally reversible polyurethane hydrogels and cosmetic, biological and medical uses
JP2836878B2 (en) 1988-08-24 1998-12-14 スリピアン，マービン，ジェイ Intraluminal sealing with biodegradable polymer material
US5843156A (en) 1988-08-24 1998-12-01 Endoluminal Therapeutics, Inc. Local polymeric gel cellular therapy
US5328471A (en) 1990-02-26 1994-07-12 Endoluminal Therapeutics, Inc. Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens
US5634946A (en) 1988-08-24 1997-06-03 Focal, Inc. Polymeric endoluminal paving process
US5213580A (en) 1988-08-24 1993-05-25 Endoluminal Therapeutics, Inc. Biodegradable polymeric endoluminal sealing process
US5575815A (en) 1988-08-24 1996-11-19 Endoluminal Therapeutics, Inc. Local polymeric gel therapy
US5256765A (en) 1989-03-09 1993-10-26 The Johns Hopkins University School Of Medicine Biodegradable poly(phosphate esters)
US5674192A (en) * 1990-12-28 1997-10-07 Boston Scientific Corporation Drug delivery
US5252318A (en) 1990-06-15 1993-10-12 Allergan, Inc. Reversible gelation compositions and methods of use
US5410016A (en) 1990-10-15 1995-04-25 Board Of Regents, The University Of Texas System Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers
CA2101773A1 (en) * 1991-01-31 1992-08-01 Toyoichi Tanaka Interpenetrating-polymer network phase-transition gels
CA2114016A1 (en) 1991-08-21 1993-03-04 Tsutomu Higashijima Methods and compositions for modulating g protein action
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
JP3356447B2 (en) * 1991-10-16 2002-12-16 テルモ株式会社 Vascular lesion embolic material composed of dried polymer gel
US5573934A (en) 1992-04-20 1996-11-12 Board Of Regents, The University Of Texas System Gels for encapsulation of biological materials
US5514379A (en) 1992-08-07 1996-05-07 The General Hospital Corporation Hydrogel compositions and methods of use
US6030442A (en) * 1994-05-13 2000-02-29 University Of Cincinnati Microporous fast response gels and methods of use
JP2535785B2 (en) * 1994-06-03 1996-09-18 工業技術院長 Vascular embolic agent
DE69531869T2 (en) 1994-07-21 2004-07-22 Sirus Pharmaceuticals Ltd. COMPOSITION CONTAINING A TISSUE ADHESIVE AND AN IMMOBILIZED THERAPEUTIC ACTIVE PARTICLE
US5643246A (en) * 1995-02-24 1997-07-01 Gel Sciences, Inc. Electromagnetically triggered, responsive gel based drug delivery device
KR100190957B1 (en) 1995-03-10 1999-06-15 김성년 Radioactive chitosan chelates, radioactive chitosan coagulates kit for the preparation of radioactive chitosan chelates, preparation and use thereof
US5939485A (en) 1995-06-19 1999-08-17 Medlogic Global Corporation Responsive polymer networks and methods of their use
US5876741A (en) * 1995-03-30 1999-03-02 Medlogic Global Corporation Chemo-mechanical expansion delivery system
WO1997009068A2 (en) * 1995-09-01 1997-03-13 University Of Washington Interactive molecular conjugates
US5766704A (en) 1995-10-27 1998-06-16 Acushnet Company Conforming shoe construction and gel compositions therefor
US5843331A (en) * 1995-11-13 1998-12-01 The Lubrizol Corporation Polymeric materials to self-regulate the level of polar activators in electrorheological fluids
JP3689897B2 (en) 1995-12-04 2005-08-31 Ｊｓｒ株式会社 Nucleic acid adsorbent
US5976648A (en) 1995-12-14 1999-11-02 Kimberly-Clark Worldwide, Inc. Synthesis and use of heterogeneous polymer gels
US5752974A (en) * 1995-12-18 1998-05-19 Collagen Corporation Injectable or implantable biomaterials for filling or blocking lumens and voids of the body
US5702361A (en) 1996-01-31 1997-12-30 Micro Therapeutics, Inc. Method for embolizing blood vessels
JP2000509014A (en) 1996-03-11 2000-07-18 フォーカル，インコーポレイテッド Polymer delivery of radionuclides and radiopharmaceuticals
US5695480A (en) 1996-07-29 1997-12-09 Micro Therapeutics, Inc. Embolizing compositions
JPH10139689A (en) * 1996-11-07 1998-05-26 Yoshihito Osada Temperature/electric field response-type copolymer
US6030634A (en) * 1996-12-20 2000-02-29 The Chinese University Of Hong Kong Polymer gel composition and uses therefor
ATE193262T1 (en) * 1997-02-14 2000-06-15 Daiwa Gravure Co Ltd EASY TO OPEN SOFT BAG
WO1998055147A2 (en) 1997-06-06 1998-12-10 Battelle Memorial Institute Reversible geling co-polymer and method of making
US6090911A (en) * 1997-10-22 2000-07-18 University Of Massachusetts Reversible hydrogels
WO1999049908A1 (en) 1998-03-31 1999-10-07 University Of Cincinnati Temperature controlled solute delivery system
US6296831B1 (en) * 1998-04-10 2001-10-02 Battelle Memorial Institute Stimulus sensitive gel with radioisotope and methods of making
US6113629A (en) 1998-05-01 2000-09-05 Micrus Corporation Hydrogel for the therapeutic treatment of aneurysms
US6316011B1 (en) 1998-08-04 2001-11-13 Madash, Llc End modified thermal responsive hydrogels
JP4932069B2 (en) 1999-01-25 2012-05-16 株式会社セルシード Acrylamide derivatives and polymers containing the derivatives
US7485317B1 (en) 1999-02-05 2009-02-03 The Regents Of The University Of California Thermo-reversible polymer for intralumenal implant
US6652883B2 (en) * 2000-03-13 2003-11-25 Biocure, Inc. Tissue bulking and coating compositions
US6660247B1 (en) * 2000-06-23 2003-12-09 Battelle Memorial Institute Multiple stimulus reversible hydrogels

Also Published As

Publication number Publication date
US20040096508A1 (en) 2004-05-20
WO2002000193A3 (en) 2003-01-03
WO2002000193A2 (en) 2002-01-03
US6660247B1 (en) 2003-12-09
US7033571B2 (en) 2006-04-25
CA2412017A1 (en) 2002-01-03
JP2004512389A (en) 2004-04-22
EP1292280A2 (en) 2003-03-19

Similar Documents

Publication Publication Date Title
AU2001276833A1 (en) Multiple stimulus reversible hydrogels
AU2001262847A1 (en) Language-understanding
AU2000267458A1 (en) Hypercomputer
AU2001254546A1 (en) Aminopiperidines
AU2001239310A1 (en) Decahydro-isoquinolines
AU2001220246A1 (en) Neckphone
AU2371601A (en) Hydrogels
AU2001258349A1 (en) Bisacylguanidine
AU2001279754A1 (en) Indoloquinazolinones
AU2001295168A1 (en) Reversible gel formation
AU2001285886A1 (en) 2-guanidino-4-aryl-quinazoline
AU2001290931A1 (en) Ski-snowboard
AU2001258924A1 (en) Microsatellite-aflp
AU4263501A (en) Colour specification
AU2001264247A1 (en) GASC1 gene
AU2001281921A1 (en) Bdellosomes
AU2001246864A1 (en) Hypotensors
AU2001291876A1 (en) Triazolo-epothilones
AU2001285743A1 (en) Adipose-related gene
AU2001284173A1 (en) Calycins
AU2001260192A1 (en) Glycinamides
AU2001226668A1 (en) Crankshaft-starter-generator
AU2001262711A1 (en) Cytoprotectors
AU5018801A (en) Offside-detection-system
AU2001275014A1 (en) Imidazoloisoquinolines